South Korean software provider Hyundai Mobis selected Israel's Cognata, a provider of simulation software and training data for driver-assistance systems and autonomous vehicles, to test its offerings.
Cognata noted that large-scale simulation provides the only environment where autonomous vehicle technology and advanced driver-assistance systems (ADAS) can be safely tested and validated.
The deal brings Cognata's technology to one of South Korea's largest automotive groups during an incredible momentum and growth in autonomous driving and ADAS in South Korea.
Lee Chang-ik, who manages autonomous vehicle simulation in Hyundai Mobis, said Cognata would accelerate their time-to-market offerings.
According to NH Investment & Securities analyst Cho Soo-hong, Hyundai Mobis should see mid to long-term earnings growth as a key automotive electronics provider for Hyundai Motor Group, set to introduce its E-GMP EV-dedicated platform in 2021.


Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft
One Percent Rule Checklist For Safer Forex Trading Risk
Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10%
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation
Tesla Revives Dojo Supercomputer Project With AI5 Chip at the Core
Proposed Rio Tinto–Glencore Merger Faces China Regulatory Hurdles and Asset Sale Pressure
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal
Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling
Baidu Shares Rise in Hong Kong After Apollo Go Robotaxi Launch in Abu Dhabi
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 



